Advocates for medicines that are unregistered in South Africa have accused the regulatory authority of not being proactive in bringing such products to market and approving their use.
Negotiating for the fair treatment of study participants and benefit sharing before a study commences does not constitute an unfair inducement. It is an ethical imperative.
Current blood pressure targets are based on information from high-income countries. This might mean that these targets are not ideal for South Africans.
Giving money to support local production of COVID-19 vaccines is a step in the right direction if it will help in resuscitating Nigeria’s vaccine production laboratory.
Vaccine hesitancy will not go away fast. In fact, there are parallels in the physical world to how quickly or slowly an object returns to its normal state.
Getting pharmacies more involved could be a game changer, particularly for reaching minorities, older adults without internet access and others left behind.
The results indicate that the vaccine efficacy in the UK was 89% for individuals who received at least two doses of vaccine. In South Africa, the vaccine efficacy was 60% in people without HIV.
The Novavax vaccine is the first that provides objective scientific evidence that it can protect people against the variant virus circulating in South Africa.
Almost half of Australian adults struggle with reading. Our recent analysis of government information on COVID-19 found many documents were inaccessible to struggling readers.
Studies in poor countries have highlighted disparities in respectful and responsive care during childbirth based on women’s socioeconomic status and other characteristics.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases
Professor and Programme Director, SA MRC Centre for Health Economics and Decision Science - PRICELESS SA (Priority Cost Effective Lessons in Systems Strengthening South Africa), University of the Witwatersrand